ARCHIVES

Study Would Try to Validate EGFR FISH as Predictive Marker for Benefit from Tarceva.

This article is from The Cancer Letter archive.

Vol. 33 No. 27 | July 13, 2007

Download PDF Visit The Full Archive

Related Articles

ASCO Publishes Two Clinical Guidelines For Treating HER2-Positive Breast Cancer

May 30, 2014

Dole to Press HCFA On Community DRG Exemptions, Calls For Meeting TO Assess Problems

March 16, 1984

DCPC advisors OK 16 Year Trial Of Screening Methods

February 15, 1991

NIH Drops Objections To Bill For Research On Environmental Causes of Breast Cancer.

May 23, 2008

Obituary: Ernst Wynder, 77, Linked Smoking, Cancer

July 23, 1999

New AIDs System For Classification Increase By 1% Cases Reported

August 1, 1986